L. Odoguardi

Clinical, exercise electrocardiographic, and pharmacologic stress echocardiographic findings for risk stratification of hypertensive patients with chest pain.

A. Desideri, R. Bigi, L. Cortigiani, 2003, The American journal of cardiology.

Genetically determined absence of HDL-cholesterol and coronary atherosclerosis

G. Assmann, H. Wiebusch, H. Funke, 1995, The Lancet.

The regional distribution of pulmonary blood flow as determined by lung scintigraphy in cardiac patients.

F. Fazio, A. Balbarini, M. Mariani, 1971, The Journal of nuclear biology and medicine.

Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease.

G. Assmann, H. Wiebusch, H. Funke, 1996, Circulation.

Prevalence of the metabolic syndrome among Italian adults according to ATP III definition.

Cristina Bianchi, Stefano Del Prato, S. Del Prato, 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[Atherogenic dyslipidemia, metabolic syndrome and cardiovascular risk].

R. Navalesi, L. Odoguardi, R. Miccoli, 1999, Cardiologia.

Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy.

C. Haffajee, A. Pinchera, L. Braverman, 1984, Annals of internal medicine.